Skip to content
healthcare.dev

rivaroxaban

NDC 71921-405, rivaroxaban, tablet, from Florida Pharmaceutical Products, LLC.

Product NDC
71921-405
Status
Listed
Labeler
Florida Pharmaceutical Products, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218445
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71921-405 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVAROXABAN2.5 mg/1

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
71921-405-067192104050660 TABLET in 1 BOTTLE (71921-405-06)
71921-405-2171921040521180 TABLET in 1 BOTTLE (71921-405-21)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f0ef9361-f06d-4028-97af-183b545f4aea
  • NADAC price for package 71921040506

    GET /v1/drugs/nadac/71921040506
  • NADAC price for package 71921040521

    GET /v1/drugs/nadac/71921040521

Use it

Look up 71921-405 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71921-405 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71921-405. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.